Zhi‐Dong Lv
- Molecular Biology
- Oncology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Molecular Medicine top 5%
- Topics
- Breast Cancer Treatment Studies (6 papers)TGF-β signaling in diseases (5 papers)Cancer Cells and Metastasis (5 papers)
- Partner nations
- China
In The Last Decade
Zhi‐Dong Lv
31 papers receiving 620 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 353
- Oncology 194
- Cancer Research 188
- Pulmonary and Respiratory Medicine 80
- Molecular Medicine 74
Countries citing papers authored by Zhi‐Dong Lv
This map shows the geographic impact of Zhi‐Dong Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Dong Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Dong Lv more than expected).
Fields of papers citing papers by Zhi‐Dong Lv
This network shows the impact of papers produced by Zhi‐Dong Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Dong Lv. The network helps show where Zhi‐Dong Lv may publish in the future.
Co-authorship network of co-authors of Zhi‐Dong Lv
This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Dong Lv. A scholar is included among the top collaborators of Zhi‐Dong Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Dong Lv. Zhi‐Dong Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 10 | |
| 6 | 18 | |
| 7 | 40 | |
| 8 | 12 | |
| 9 | 23 | |
| 10 | 20 | |
| 11 | Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects. | 7 |
| 12 | CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo. | 16 |
| 13 | 4 | |
| 14 | 4 | |
| 15 | 10 | |
| 16 | 65 | |
| 17 | 13 | |
| 18 | 7 | |
| 19 | 31 | |
| 20 | 38 |
About Zhi‐Dong Lv
Zhi‐Dong Lv is a scholar working on Cancer Research, Oncology and Gastroenterology, having authored 32 papers that have together received 632 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), TGF-β signaling in diseases (5 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Molecular Medicine (74 citations), Cancer Research (188 citations) and Oncology (194 citations). Zhi‐Dong Lv has collaborated with scholars based in China. Frequent co-authors include Haibo Wang, Funian Li, Zhaochuan Yang, Xiangping Liu, Bin Kong, Liying Jin, Weijun Zhao, Qian Dong, Huimian Xu and Bin Kong. Their work appears in journals such as Advanced Functional Materials, Journal of Cellular Physiology and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.